Report Detail
Global Opioids Agonist Drugs Market Professional Survey Report 2019
- RnM3727461 |
- 05 September, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Opioid drugs act on the opioid receptors present in the central and peripheral nervous system. The drug class primarily used in relieving pain includes natural, semi-synthetic, and synthetic opioids.Opioids can be administered as oral pills, parenteral, liquids, patches, or lozenges.
Legalizing Cannabis to Impact Opioids Agonist Drugs Market Growth
The global Opioids Agonist Drugs market was valued at 18600 million US$ in 2018 and will reach 25900 million US$ by the end of 2025, growing at a CAGR of 4.2% during 2019-2025.
This report focuses on Opioids Agonist Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Opioids Agonist Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Opioids Agonist Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Opioids Agonist Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone
Segment by Application
Pain Management
Cough Treatment
Diarrhea Treatment
Table of Contents
Executive Summary
1 Industry Overview of Opioids Agonist Drugs
- 1.1 Definition of Opioids Agonist Drugs
- 1.2 Opioids Agonist Drugs Segment by Type
- 1.2.1 Global Opioids Agonist Drugs Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Codeine
- 1.2.3 Fentanyl
- 1.2.4 Meperidine
- 1.2.5 Methadone
- 1.2.6 Morphine
- 1.2.7 Hydrocodone
- 1.3 Opioids Agonist Drugs Segment by Applications
- 1.3.1 Global Opioids Agonist Drugs Consumption Comparison by Applications (2014-2025)
- 1.3.2 Pain Management
- 1.3.3 Cough Treatment
- 1.3.4 Diarrhea Treatment
- 1.4 Global Opioids Agonist Drugs Overall Market
- 1.4.1 Global Opioids Agonist Drugs Revenue (2014-2025)
- 1.4.2 Global Opioids Agonist Drugs Production (2014-2025)
- 1.4.3 North America Opioids Agonist Drugs Status and Prospect (2014-2025)
- 1.4.4 Europe Opioids Agonist Drugs Status and Prospect (2014-2025)
- 1.4.5 China Opioids Agonist Drugs Status and Prospect (2014-2025)
- 1.4.6 Japan Opioids Agonist Drugs Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Opioids Agonist Drugs Status and Prospect (2014-2025)
- 1.4.8 India Opioids Agonist Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Opioids Agonist Drugs
- 2.3 Manufacturing Process Analysis of Opioids Agonist Drugs
- 2.4 Industry Chain Structure of Opioids Agonist Drugs
3 Development and Manufacturing Plants Analysis of Opioids Agonist Drugs
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Opioids Agonist Drugs Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Opioids Agonist Drugs
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Opioids Agonist Drugs Production and Capacity Analysis
- 4.2 Opioids Agonist Drugs Revenue Analysis
- 4.3 Opioids Agonist Drugs Price Analysis
- 4.4 Market Concentration Degree
5 Opioids Agonist Drugs Regional Market Analysis
- 5.1 Opioids Agonist Drugs Production by Regions
- 5.1.1 Global Opioids Agonist Drugs Production by Regions
- 5.1.2 Global Opioids Agonist Drugs Revenue by Regions
- 5.2 Opioids Agonist Drugs Consumption by Regions
- 5.3 North America Opioids Agonist Drugs Market Analysis
- 5.3.1 North America Opioids Agonist Drugs Production
- 5.3.2 North America Opioids Agonist Drugs Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Opioids Agonist Drugs Import and Export
- 5.4 Europe Opioids Agonist Drugs Market Analysis
- 5.4.1 Europe Opioids Agonist Drugs Production
- 5.4.2 Europe Opioids Agonist Drugs Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Opioids Agonist Drugs Import and Export
- 5.5 China Opioids Agonist Drugs Market Analysis
- 5.5.1 China Opioids Agonist Drugs Production
- 5.5.2 China Opioids Agonist Drugs Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Opioids Agonist Drugs Import and Export
- 5.6 Japan Opioids Agonist Drugs Market Analysis
- 5.6.1 Japan Opioids Agonist Drugs Production
- 5.6.2 Japan Opioids Agonist Drugs Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Opioids Agonist Drugs Import and Export
- 5.7 Southeast Asia Opioids Agonist Drugs Market Analysis
- 5.7.1 Southeast Asia Opioids Agonist Drugs Production
- 5.7.2 Southeast Asia Opioids Agonist Drugs Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Opioids Agonist Drugs Import and Export
- 5.8 India Opioids Agonist Drugs Market Analysis
- 5.8.1 India Opioids Agonist Drugs Production
- 5.8.2 India Opioids Agonist Drugs Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Opioids Agonist Drugs Import and Export
6 Opioids Agonist Drugs Segment Market Analysis (by Type)
- 6.1 Global Opioids Agonist Drugs Production by Type
- 6.2 Global Opioids Agonist Drugs Revenue by Type
- 6.3 Opioids Agonist Drugs Price by Type
7 Opioids Agonist Drugs Segment Market Analysis (by Application)
- 7.1 Global Opioids Agonist Drugs Consumption by Application
- 7.2 Global Opioids Agonist Drugs Consumption Market Share by Application (2014-2019)
8 Opioids Agonist Drugs Major Manufacturers Analysis
- 8.1 Purdue Pharma
- 8.1.1 Purdue Pharma Opioids Agonist Drugs Production Sites and Area Served
- 8.1.2 Purdue Pharma Product Introduction, Application and Specification
- 8.1.3 Purdue Pharma Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Titan pharmaceuticals
- 8.2.1 Titan pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
- 8.2.2 Titan pharmaceuticals Product Introduction, Application and Specification
- 8.2.3 Titan pharmaceuticals Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Boehringer Ingelheim
- 8.3.1 Boehringer Ingelheim Opioids Agonist Drugs Production Sites and Area Served
- 8.3.2 Boehringer Ingelheim Product Introduction, Application and Specification
- 8.3.3 Boehringer Ingelheim Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Janssen Pharmaceuticals, Inc
- 8.4.1 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production Sites and Area Served
- 8.4.2 Janssen Pharmaceuticals, Inc Product Introduction, Application and Specification
- 8.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Sanofi
- 8.5.1 Sanofi Opioids Agonist Drugs Production Sites and Area Served
- 8.5.2 Sanofi Product Introduction, Application and Specification
- 8.5.3 Sanofi Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Sun Pharmaceuticals
- 8.6.1 Sun Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
- 8.6.2 Sun Pharmaceuticals Product Introduction, Application and Specification
- 8.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Mallinckrodt Pharmaceuticals
- 8.7.1 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production Sites and Area Served
- 8.7.2 Mallinckrodt Pharmaceuticals Product Introduction, Application and Specification
- 8.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Egalet Corporation
- 8.8.1 Egalet Corporation Opioids Agonist Drugs Production Sites and Area Served
- 8.8.2 Egalet Corporation Product Introduction, Application and Specification
- 8.8.3 Egalet Corporation Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Endo Pharmaceuticals Inc.
- 8.9.1 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production Sites and Area Served
- 8.9.2 Endo Pharmaceuticals Inc. Product Introduction, Application and Specification
- 8.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Allergan, Plc
- 8.10.1 Allergan, Plc Opioids Agonist Drugs Production Sites and Area Served
- 8.10.2 Allergan, Plc Product Introduction, Application and Specification
- 8.10.3 Allergan, Plc Opioids Agonist Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Pfizer Inc
9 Development Trend of Analysis of Opioids Agonist Drugs Market
- 9.1 Global Opioids Agonist Drugs Market Trend Analysis
- 9.1.1 Global Opioids Agonist Drugs Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Opioids Agonist Drugs Regional Market Trend
- 9.2.1 North America Opioids Agonist Drugs Forecast 2019-2025
- 9.2.2 Europe Opioids Agonist Drugs Forecast 2019-2025
- 9.2.3 China Opioids Agonist Drugs Forecast 2019-2025
- 9.2.4 Japan Opioids Agonist Drugs Forecast 2019-2025
- 9.2.5 Southeast Asia Opioids Agonist Drugs Forecast 2019-2025
- 9.2.6 India Opioids Agonist Drugs Forecast 2019-2025
- 9.3 Opioids Agonist Drugs Market Trend (Product Type)
- 9.4 Opioids Agonist Drugs Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Opioids Agonist Drugs Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Opioids Agonist Drugs. Industry analysis & Market Report on Opioids Agonist Drugs is a syndicated market report, published as Global Opioids Agonist Drugs Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Opioids Agonist Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
